Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/10817
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
- IOC - Artigos de Periódicos [12967]
Metadata
Show full item record
PREVALENCE AND GENOMIC CHARACTERIZATION OF G2P[4] GROUP A ROTAVIRUS STRAINS DURING MONOVALENT VACCINE INTRODUCTION IN BRAZIL
Author
Gómez, Mariela Martínez
Costa, Filipe Aníbal Carvalho
Volotão, Eduardo de Mello
Rose, Tatiana Lundgren
Silva, Marcelle Figueira Marques da
Fialho, Alexandre Madi
Assis, Rosane Maria S
Andrade, Juliana da Silva Ribeiro de
Sá, Ana Caroline Costa
Zeller, Mark
Heylen, Elisabeth
Matthijnssens, Jelle
Leite, José Paulo Gagliardi
Costa, Filipe Aníbal Carvalho
Volotão, Eduardo de Mello
Rose, Tatiana Lundgren
Silva, Marcelle Figueira Marques da
Fialho, Alexandre Madi
Assis, Rosane Maria S
Andrade, Juliana da Silva Ribeiro de
Sá, Ana Caroline Costa
Zeller, Mark
Heylen, Elisabeth
Matthijnssens, Jelle
Leite, José Paulo Gagliardi
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
University of Leuven. Rega Institute for Medical Research. Department of Microbiology and Immunology.Laboratory of Clinical and Epidemiological Virology. Leuven, Belgium.
University of Leuven. Rega Institute for Medical Research. Department of Microbiology and Immunology.Laboratory of Clinical and Epidemiological Virology. Leuven, Belgium.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
University of Leuven. Rega Institute for Medical Research. Department of Microbiology and Immunology.Laboratory of Clinical and Epidemiological Virology. Leuven, Belgium.
University of Leuven. Rega Institute for Medical Research. Department of Microbiology and Immunology.Laboratory of Clinical and Epidemiological Virology. Leuven, Belgium.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Virologia Comparada e Ambiental. Rio de Janeiro, RJ, Brasil.
Abstract
This study aims to: estimate the prevalence of G2P[4] rotaviruses in Brazil between 2001–2011 from
patients with acute gastroenteritis; perform phylogenetic analyses of G2P[4] Brazilian strains (from vaccinated
and non-vaccinated children) based on VP7 and VP8⁄ encoding genes and analyze the antigenic
regions of these proteins comparing with RV1; and assess the full genetic background of eleven selected
Brazilian strains. The G2P[4] detection rate among RVA positive samples was 0/157 in 2001, 3/226 (1.3%)
in 2002, 0/514 in 2003, 0/651 in 2004, 31/344 (9%)/2005, 112/227 (49%)/2006, 139/211 (66%)/2007, 240/
284 (85%)/2008, 66/176 (37.5%)/2009, 367/422 (87%)/2010 and 75/149 (50%)/2011. For the VP7 and VP8⁄
encoding genes, 52 sequences were analyzed and shared up to 99% nucleotide identity with other contemporary
G2P[4] strains detected worldwide, grouping into different clusters. Most differences inside
antigenic epitopes of VP7 and VP8⁄ have been maintained in the G2P[4] Brazilian strains along the years,
and all were present before RV1 introduction. Eleven G2P[4] strains (4-vaccinated/7-non-vaccinated)
were completely characterized and possessed the typical DS-1-like genotype constellation (G2-P[4]-I2-
R2-C2-M2-A2-N2-T2-E2-H2) sharing up to 99% of nucleotide identity with contemporary worldwide
strains. Reassortments between Brazilian G2P[4] human strains were observed. In conclusion, the data
obtained in the current study suggests that implementation of RV1 vaccination might not influence
the genetic diversity observed in G2P[4] analyzed strains. Several factors might have contributed to
the increased prevalence of this genotype in Brazil since 2005: the introduction of RV1 into the Brazilian
National Immunization Program has resulted in a decrease in the relative prevalence of predominant
Wa-like RVA strains facilitating the increase of the heterotypic (DS-1-like) RVA strain G2P[4] in the
Brazilian population; the genetic diversity found in different geographical regions throughout the years
before, and after the introduction of RV1; the long period of low or no circulation of this genotype in
Brazil previous to RV1 introduction could have created favorable conditions for the accumulation of
immunological susceptible individuals.
Share